Cerebrovascular disease encompasses a spectrum of disorders affecting the blood vessels of the brain, including small vessel disease, large vessel atherosclerosis, cerebral amyloid angiopathy, and microinfarcts. These vascular pathologies are increasingly recognized as major contributors to cognitive decline and dementia, both as primary causes (vascular dementia) and as important co-factors in Alzheimer's disease and other neurodegenerative conditions. [@cerebrovascular2020]
The intersection of cerebrovascular disease and neurodegenerative processes creates a vicious cycle: vascular damage reduces cerebral blood flow and compromises the [blood-brain barrier](/entities/blood-brain-barrier), while neurodegenerative proteinopathies further damage cerebral vessels and [pericytes](/cell-types/pericytes). This bidirectional relationship has major implications for diagnosis, treatment, and prevention of dementia. [@vascular2021]
Cerebrovascular Disease Pathways in Neurodegeneration
```mermaid flowchart TD A["Risk Factors"] --> B["Small Vessel Disease"] A --> C["Large Vessel Pathology"] A --> D["Cerebral Amyloid Angiopathy"]
B --> B["1Lipohyalinosis"] B --> B["2Fibrinoid Necrosis"] B --> B["3Microaneurysms"]
C --> C["1Atherosclerosis"] C --> C["2Arterial Dissection"] C --> C["3Embolism"]
D --> DA["Abeta Deposition"] D --> E["Vascular Damage"]
...
Cerebrovascular Disease in Neurodegeneration
Introduction
Cerebrovascular disease encompasses a spectrum of disorders affecting the blood vessels of the brain, including small vessel disease, large vessel atherosclerosis, cerebral amyloid angiopathy, and microinfarcts. These vascular pathologies are increasingly recognized as major contributors to cognitive decline and dementia, both as primary causes (vascular dementia) and as important co-factors in Alzheimer's disease and other neurodegenerative conditions. [@cerebrovascular2020]
The intersection of cerebrovascular disease and neurodegenerative processes creates a vicious cycle: vascular damage reduces cerebral blood flow and compromises the [blood-brain barrier](/entities/blood-brain-barrier), while neurodegenerative proteinopathies further damage cerebral vessels and [pericytes](/cell-types/pericytes). This bidirectional relationship has major implications for diagnosis, treatment, and prevention of dementia. [@vascular2021]
Cerebrovascular Disease Pathways in Neurodegeneration
Mermaid diagram (expand to render)
Gene-to-Phenotype Pathway in Cerebrovascular Neurodegeneration
Small vessel disease (SVD) is the most common form of cerebrovascular pathology in aging and dementia. It affects the small arterioles, capillaries, and venules of the brain, leading to:
White matter hyperintensities: Lesions in the deep white matter visible on MRI
Lacunar infarcts: Small subcortical infarcts
Microbleeds: Small hemorrhages detectable on MRI
Perivascular spaces: Enlarged perivascular spaces
The pathogenesis of SVD involves:
Lipohyalinosis: Fibrinoid necrosis of vessel walls
Fibrinoid necrosis: Proteinaceous deposition in vessel walls
[Unknown, Cerebral small vessel disease: from pathogenesis to clinical manifestations (Can J Neurol Sci, 2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34538359/)
[Unknown, Cerebral amyloid angiopathy: emerging concepts in pathogenesis and clinical implications (Nat Rev Neurol, 2023) (2023)](https://doi.org/10.1038/s41582-023-00786-4)
[Unknown, Pericyte loss leads to neurovascular dysfunction and neurodegenerative pathways (Nat Rev Neurosci, 2022) (2022)](https://doi.org/10.1038/s41583-022-00598-1)
[Unknown, Amyloid-beta and cerebral vessels in Alzheimer's disease (Cell Mol Neurobiol, 2023) (2023)](https://doi.org/10.1007/s10571-023-01326-8)
[Unknown, Tau and the neurovascular unit (Trends Neurosci, 2023) (2023)](https://doi.org/10.1016/j.tins.2023.05.009)
[Metabolic reprogramming in neurodegenerative disease](/analysis/SDA-2026-04-02-gap-v2-5d0e3052) 🔄
[Cell type vulnerability in Alzheimer's Disease (SEA-AD data)](/analysis/SDA-2026-04-02-gap-seaad-20260402025452) 🔄
[Autophagy-lysosome pathway convergence across neurodegenerative diseases](/analysis/SDA-2026-04-01-gap-011) 🔄
[What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's disease pathogenesi](/analysis/SDA-2026-04-01-gap-20260401-225149) 🔄
[What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's disease pathogenesi](/analysis/SDA-2026-04-01-gap-20260401-225155) 🔄
Pathway Diagram
The following diagram shows the key molecular relationships involving Cerebrovascular Disease in Neurodegeneration discovered through SciDEX knowledge graph analysis: